Management of incidental gallbladder polyps: Do not sacrifice the gallbladder - try ursodiol first!
Main Article Content
Abstract
N/A
Article Details
How to Cite
SAMUEL, Isaac.
Management of incidental gallbladder polyps: Do not sacrifice the gallbladder - try ursodiol first!.
Medical Research Archives, [S.l.], v. 13, n. 2, feb. 2025.
ISSN 2375-1924.
Available at: <https://esmed.org/MRA/mra/article/view/6310>. Date accessed: 16 mar. 2025.
doi: https://doi.org/10.18103/mra.v13i2.6310.
Section
Editorial
The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.
References
1. Kamaya A, Fung C, Szpakowski JL, et al. Management of incidentally detected gallbladder polyps: Society of radiologists in ultrasound consensus conference recommendations. Radiology. 2022;305(2):277-89. Doi:10.1148/radiol.213079.
2. Foley KG, Lahaye MJ, Thoeni RF, et al. Management and follow-up of gallbladder polyps: Updated joint guidelines between the ESGAR, EAES, EFISDS and ESGE. Eur Radiol. 2022;32(5):3358-68. Doi:10.1007/s00330-021-08384-w.
3. Wiles R, Thoeni RF, Barbu ST, et al. Management and follow-up of gallbladder polyps : Joint guidelines between the european society of gastrointestinal and abdominal radiology (ESGAR), european association for endoscopic surgery and other interventional techniques (EAES), international society of digestive surgery - european federation (EFISDS) and european society of gastrointestinal endoscopy (ESGE). Eur Radiol. 2017;27(9):3856-66. Doi:10.1007/s00330-017-4742-y.
4. Kalbi DP, Bapatla A, Chaudhary AJ, Bashar S, Iqbal S. Surveillance of gallbladder polyps: A literature review. Cureus. 2021;13(7):e16113. Doi:10.7759/cureus.16113.
5. Runde R, Auyang ED, Ng R, et al. The gallbladder: What's new in 2022? Abdom Radiol (NY). 2023;48(1):2-28. Doi:10.1007/s00261-022-03429-0.
6. Szpakowski JL, Tucker LY. Outcomes of gallbladder polyps and their association with gallbladder cancer in a 20-year cohort. JAMA Netw Open. 2020;3(5):e205143. Doi:10.1001/jamanetworkopen.2020.5143.
7. Pillenahalli Maheshwarappa R, Menda Y, Graham MM, Boukhar SA, Zamba GKD, Samuel I. Association of gallbladder hyperkinesia with acalculous chronic cholecystitis: A case-control study. Surgery. 2020;168(5):800-8. Doi:10.1016/j.surg.2020.06.005.
8. Samuel I. The chronic acalculous symptomatic hyperkinetic (CASPER) gallbladder or "the excitable gallbladder”. JSM Gastroenterol Hepatol. 2023;10(1):1113. Doi:10.47739/2373-9487/1113.
9. Barcia JJ. Histologic analysis of chronic inflammatory patterns in the gallbladder: Diagnostic criteria for reporting cholecystitis. Ann Diagn Pathol. 2003;7(3):147-53. Doi:10.1016/s1092-9134(03)00011-x.
10. Wu L, Wang Y, Zhu S, et al. Changes in plasma bile acids are associated with gallbladder stones and polyps. BMC Gastroenterology. 2020;20(1):363. Doi:10.1186/s12876-020-01512-8.
11. Guarino MP, Cocca S, Altomare A, Emerenziani S, Cicala M. Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed. World J Gastroenterol. 2013;19(31):5029-34. Doi:10.3748/wjg.v19.i31.5029.
12. Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169(1):91-6. Doi:10.1016/s0002-9610(99)80115-9.
13. Patel N, Chick JFB, Gemmete JJ, et al. Interventional radiology-operated cholecystoscopy for the management of symptomatic cholelithiasis: Approach, technical success, safety, and clinical outcomes. Am J Roentgenol. 2018;210(5):1164-71. Doi:10.2214/AJR.17.18690.
14. Favero GD, Mario FD, Meggiato T, et al. Disappearance of gallbladder wall lesions after oral bile acids treatment—a pilot study. Current Therapeutic Research. 1993;54(4):384-8. Doi:10.1016/s0011-393x(05)80640-x.
15. Il'chenko AA, Orlova Iu N. [efficacy of ursodeoxycholic acid in gallbladder cholesterosis accompanied by cholecystolithiasis]. Eksp Klin Gastroenterol. 2003(1):46-50, 182.
2. Foley KG, Lahaye MJ, Thoeni RF, et al. Management and follow-up of gallbladder polyps: Updated joint guidelines between the ESGAR, EAES, EFISDS and ESGE. Eur Radiol. 2022;32(5):3358-68. Doi:10.1007/s00330-021-08384-w.
3. Wiles R, Thoeni RF, Barbu ST, et al. Management and follow-up of gallbladder polyps : Joint guidelines between the european society of gastrointestinal and abdominal radiology (ESGAR), european association for endoscopic surgery and other interventional techniques (EAES), international society of digestive surgery - european federation (EFISDS) and european society of gastrointestinal endoscopy (ESGE). Eur Radiol. 2017;27(9):3856-66. Doi:10.1007/s00330-017-4742-y.
4. Kalbi DP, Bapatla A, Chaudhary AJ, Bashar S, Iqbal S. Surveillance of gallbladder polyps: A literature review. Cureus. 2021;13(7):e16113. Doi:10.7759/cureus.16113.
5. Runde R, Auyang ED, Ng R, et al. The gallbladder: What's new in 2022? Abdom Radiol (NY). 2023;48(1):2-28. Doi:10.1007/s00261-022-03429-0.
6. Szpakowski JL, Tucker LY. Outcomes of gallbladder polyps and their association with gallbladder cancer in a 20-year cohort. JAMA Netw Open. 2020;3(5):e205143. Doi:10.1001/jamanetworkopen.2020.5143.
7. Pillenahalli Maheshwarappa R, Menda Y, Graham MM, Boukhar SA, Zamba GKD, Samuel I. Association of gallbladder hyperkinesia with acalculous chronic cholecystitis: A case-control study. Surgery. 2020;168(5):800-8. Doi:10.1016/j.surg.2020.06.005.
8. Samuel I. The chronic acalculous symptomatic hyperkinetic (CASPER) gallbladder or "the excitable gallbladder”. JSM Gastroenterol Hepatol. 2023;10(1):1113. Doi:10.47739/2373-9487/1113.
9. Barcia JJ. Histologic analysis of chronic inflammatory patterns in the gallbladder: Diagnostic criteria for reporting cholecystitis. Ann Diagn Pathol. 2003;7(3):147-53. Doi:10.1016/s1092-9134(03)00011-x.
10. Wu L, Wang Y, Zhu S, et al. Changes in plasma bile acids are associated with gallbladder stones and polyps. BMC Gastroenterology. 2020;20(1):363. Doi:10.1186/s12876-020-01512-8.
11. Guarino MP, Cocca S, Altomare A, Emerenziani S, Cicala M. Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed. World J Gastroenterol. 2013;19(31):5029-34. Doi:10.3748/wjg.v19.i31.5029.
12. Sugerman HJ, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169(1):91-6. Doi:10.1016/s0002-9610(99)80115-9.
13. Patel N, Chick JFB, Gemmete JJ, et al. Interventional radiology-operated cholecystoscopy for the management of symptomatic cholelithiasis: Approach, technical success, safety, and clinical outcomes. Am J Roentgenol. 2018;210(5):1164-71. Doi:10.2214/AJR.17.18690.
14. Favero GD, Mario FD, Meggiato T, et al. Disappearance of gallbladder wall lesions after oral bile acids treatment—a pilot study. Current Therapeutic Research. 1993;54(4):384-8. Doi:10.1016/s0011-393x(05)80640-x.
15. Il'chenko AA, Orlova Iu N. [efficacy of ursodeoxycholic acid in gallbladder cholesterosis accompanied by cholecystolithiasis]. Eksp Klin Gastroenterol. 2003(1):46-50, 182.